Patents

Lee Pharma Limited was established in 1997 in India it is a research-driven company with a critical focus on the development, synthesis, and commercialization of new products and cost-effective processes.

We manufacture several intermediate chemicals, Active Pharmaceutical Ingredients & Semi-finished Dosage Forms (Pellets & Granules), and Finished Formulations. Our expertise in the field won us, numerous clients, in India as well as across the globe.

Lee Pharma Manufacturing facilities are approved by several international regulatory bodies such as USFDA, EUGMP, WHO GMP etc.

Process Patents

Granted

Preparation of Linezolid & its novel intermediate	US 9,376,407 B2; granted on 28-06-2016.
Preparation of Linezolid & its novel intermediate	EP 2595968 B1; granted on 09.09.2015

Filed

Novel Oxazolidinone Antibacterial Compound	IN2254/CHE/2014
New Chemical Entity (LDD012013)	IN5063/CHE/2013A PCT/IN2014/000497
Stable Amorphous Form of Dipeptidyl Peptidase4(dpp4) enzyme Inhibitor	TEMP/E1/4173/2017CHE
A Novel process for the preparation of Crystalline Linezolid Form -III	PCT/IN2016/050454
Sitagliptin Phosphate Monhydrate	Application No. : PCT/IB/2015/051312
Montelukast Pharma	Application No. : 811/CHE/2013
Lurasidone Dicarboxylic Intermediate	Application No. : PCT/IN2013/000149
Saxagliptin Adamantylglycine intermediate	Application No. : 4256/CHE/2007
Anhydrous Linezolid Crystalline Form-II	US Patent Application No. : 13/820565 WO 2012114354
Linezolid Form-II: European Patent Application	No. 12716665